title: Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse.
authors.affiliation: Department of Histology and Neurobiology, Karolinska Institutet, Stockholm, Sweden.
authors.forename: A M
authors.initials: AM
authors.lastname: Janson
authors.forename: K
authors.initials: K
authors.lastname: Fuxe
authors.forename: E
authors.initials: E
authors.lastname: Sundström
authors.forename: L F
authors.initials: LF
authors.lastname: Agnati
authors.forename: M
authors.initials: M
authors.lastname: Goldstein
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D009410:Nerve Degeneration / Q000187:drug effects*; D009538:Nicotine / Q000008:administration & dosage*; D011725:Pyridines / Q000494:pharmacology*; D011954:Receptors, Dopamine / Q000187:drug effects*; D013378:Substantia Nigra / Q000187:drug effects* / Q000378:metabolism
chemical_list: D011725:Pyridines; D011954:Receptors, Dopamine; D009538:Nicotine; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine